BCYC - Company ID 0001761612
The table below shows BICYCLE THERAPEUTICS plc's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$65.92M | -$86.37M | -$70.87M | -$46.41M | -$26.40M | -$13.71M |
| Capital expenditure | $713.00K | $604.00K | $12.00K | $2.10M | $4.76M | $623.00K |
| Investing cash flow | -$713.00K | -$604.00K | -$12.00K | -$2.10M | -$4.76M | -$623.00K |
| Dividends paid | - | - |
BICYCLE THERAPEUTICS plc reported operating cash flow of -$249.68M for fiscal year 2025. That is down 51.6% from -$164.72M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$1.42M (FY 2017) to -$249.68M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$54.00K | -$41.00K | $1.87M | $2.72M | $450.00K | $74.06M |